Glucosamine is a natural amino sugar and a key precursor in the biosynthesis of glycosaminoglycans (GAGs) and proteoglycans, which are essential structural components of articular cartilage and synovial fluid. In its therapeutic form, it is typically derived from shellfish exoskeletons (glucosamine sulfate) or produced synthetically (glucosamine hydrochloride). At a dose of 1500mg once daily, it is a first-line symptomatic slow-acting drug for osteoarthritis (SYSADOA), primarily used to alleviate pain, improve joint function, and potentially modify disease progression by stimulating the synthesis of cartilage matrix components.
Adult: 1500mg once daily. Alternatively, 500mg three times daily or 750mg twice daily.
Note: Take with meals to improve gastrointestinal tolerance. Can be taken as a single daily dose or in divided doses. Tablets/capsules should be swallowed whole with a full glass of water. Consistent daily use is required for effect.
Glucosamine serves as a substrate for the biosynthesis of glycosaminoglycans (GAGs) like hyaluronic acid, keratan sulfate, and chondroitin sulfate, which are integral to proteoglycan structure in cartilage. It stimulates chondrocyte production of proteoglycans and may have mild anti-inflammatory effects by inhibiting NF-ÎșB and other inflammatory pathways. It may also reduce the activity of cartilage-degrading enzymes like matrix metalloproteinases (MMPs) and aggrecanases.
Pregnancy: Category C (US FDA). Animal reproduction studies not conclusive. Not recommended during pregnancy due to lack of adequate human data. Use only if potential benefit justifies potential risk.
Driving: Glucosamine may cause drowsiness or dizziness in some individuals. Caution advised when driving or operating machinery until response is known.
| Warfarin/Acencocoumarol | May potentiate anticoagulant effect, increasing INR and bleeding risk. | Major |
| Antidiabetic Drugs (e.g., Metformin, Glimepiride, Insulin) | Theoretical risk of reducing efficacy or causing insulin resistance. Monitor blood glucose levels. | Moderate |
| Acetaminophen (Paracetamol) | Possible reduced absorption or efficacy of glucosamine (data conflicting). | Minor |
| Doxorubicin / Etoposide | In-vitro evidence suggests glucosamine may reduce chemotherapeutic efficacy. | Moderate (Theoretical) |
| Cyclosporine | May increase cyclosporine bioavailability, requiring monitoring of levels. | Moderate |
Same composition (Glucosamine (1500mg)), different brands: